La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Dr. Lal PathLabs Bilan de santé
Santé financière contrôle des critères 5/6
Dr. Lal PathLabs possède un total de capitaux propres de ₹18.9B et une dette totale de ₹2.5B, ce qui porte son ratio d'endettement à 13.1%. Son actif total et son passif total sont ₹24.6B et de ₹5.7B. L'EBIT de Dr. Lal PathLabs est ₹4.9B ce qui fait que son ratio de couverture des intérêts -17.5. Elle dispose de liquidités et de placements à court terme de ₹9.4B.
Informations clés
13.1%
Ratio d'endettement
₹2.47b
Dette
| Ratio de couverture des intérêts | -17.5x |
| Argent liquide | ₹9.43b |
| Fonds propres | ₹18.85b |
| Total du passif | ₹5.71b |
| Total des actifs | ₹24.56b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Recent updates
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve
May 21What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
May 25Do Dr. Lal PathLabs's (NSE:LALPATHLAB) Earnings Warrant Your Attention?
Apr 28Analyse de la situation financière
Passif à court terme: Les actifs à court terme de LALPATHLAB ( ₹11.3B ) dépassent ses passifs à court terme ( ₹4.7B ).
Passif à long terme: Les actifs à court terme de LALPATHLAB ( ₹11.3B ) dépassent ses passifs à long terme ( ₹1.1B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: LALPATHLAB dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de LALPATHLAB est passé de 0% à 13.1% au cours des 5 dernières années.
Couverture de la dette: La dette de LALPATHLAB est bien couverte par le flux de trésorerie opérationnel ( 216.8% ).
Couverture des intérêts: LALPATHLAB gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.